Fluorescence polarization assays for determining clostridial toxin activity

Details for Australian Patent Application No. 2005333632 (hide)

Owner Allergan, Inc.

Inventors Verhagen, Marc; Gilmore, Marcella A.; Aoki, Kei Roger; Steward, Lance E.; Williams, Dudley J.

Agent Davies Collison Cave

Pub. Number AU-B-2005333632

PCT Pub. Number WO2007/001358

Priority 10/948,097 22.09.04 US

Filing date 9 September 2005

Wipo publication date 4 January 2007

Acceptance publication date 22 December 2011

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C12N 9/52 (2006.01) Enzymes, e.g. ligases (6.) - derived from bacteria

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2007/001358 Priority application(s): WO2007/001358

22 December 2011 Application Accepted

  Published as AU-B-2005333632

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005333666-Delivery of active proteins to the central nervous system using phage vectors

2005333609-Stacked layer electrode for organic electronic devices